NMC Healthcare is the largest private healthcare company in the UAE and ranks amongst the leading fertility service providers in the world. Over the last 46 years, NMC has earned the trust of millions, thanks to its personalized care, genuine concern and a sincere commitment to the overall well-being of the patient.
NMC was the first company from Abu Dhabi to list on the London Stock Exchange and is now part of the premium FTSE 100 Index, an elite club of top 100 blue-chip companies by market cap. NMC's strategic acquisitions coupled with its legacy institutions have allowed us to fill the service gap in our healthcare delivery system and offer a continuum of care to patients.
Today, the company has put the key components in place to create a strong, inter-connected, integrated multi-vertical and multi-brand private healthcare network with the scalability and flexibility to grow our operations in the future. With a team of over 2,000 doctors and 20,000 paramedical and support personnel, NMC owns and manages over 200 healthcare facilities that includes hospitals, medical centres, long term care facilities, day surgery centres, fertility clinics and home health services. Every year, over 8.5 million patients are treated by NMC doctors across UAE, Saudi Arabia, Kuwait, Oman, Yemen, Jordan, Egypt, Kenya, Seychelles, United Kingdom, Spain, Italy, Denmark, Latvia, Sweden, Slovakia, USA, Colombia and Brazil.
At AstraZeneca, we believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines.
We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: respiratory and autoimmunity, cardiovascular, renal and metabolic disease and oncology.
Our science leverages our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partner with like-minded science-led companies.
As a global, innovation-driven biopharmaceutical company that spans discovery, development, manufacturing, distribution and worldwide commercialisation, we are well-placed to turn innovative molecules into medicines that are life changing.
Through leading in science, we are confident that we can transform the lives of patients around the world. In doing so, we will return to growth and deliver value to our shareholders.
Mubadala is a pioneering global investor, deploying capital with integrity and ingenuity to accelerate economic growth for the long-term benefit of Abu Dhabi. As Abu Dhabi’s leading strategic investment company, Mubadala is active in 13 sectors and more than 30 countries around the world, creating lasting value for our shareholder, the Government of Abu Dhabi.
Our work includes the development of global industrial champions in sectors such as aerospace, ICT, semiconductors, metals & mining and renewable energy, utilities, and the management of diverse financial holdings. We build on legacy expertise in oil and gas to invest across the hydrocarbon spectrum, and enhance the UAE’s growth potential through investments in healthcare, real estate and defense services. Our investment approach prioritizes partnership with best-in-class organizations and a commitment to the highest standards of governance.
Cleveland Clinic Abu Dhabi, part of Mubadala’s network of world-class healthcare providers, is a multispecialty hospital on Al Maryah Island in Abu Dhabi, UAE. Cleveland Clinic Abu Dhabi is a unique and unparalleled extension of US-based Cleveland Clinic’s model of care, specifically designed to address a range of complex and critical care requirements unique to the Abu Dhabi population.
Cleveland Clinic Abu Dhabi has the following Institutes: Heart & Vascular, Neurological, Digestive Disease, Eye, Respiratory, Critical Care, Surgical Subspecialties, Medical Subspecialties, Emergency Medicine, Anesthesiology, Pathology & Laboratory Medicine, Imaging, Quality & Patient Safety, and Clinical & Nursing. In all, more than 30 medical and surgical specialties are represented at Cleveland Clinic Abu Dhabi.
The facilities at Cleveland Clinic Abu Dhabi combine state-of-the-art amenities and world-class service standards. The hospital is a 364 (expandable to 490) bed facility, with five clinical floors, three diagnostic and treatment levels, and 13 floors of critical and acute inpatient units. It is a physician-led medical facility served by North American/European Board Certified (or equivalent) physicians. Cleveland Clinic Abu Dhabi provides patients in the region direct access to the world’s best healthcare providers and Cleveland Clinic’s unique model of care, reducing their need to travel abroad for treatment.
Cleveland Clinic Abu Dhabi – Al Ain began offering select medical services in December 2017. The facility is located on the Tawam Hospital Campus in Al Ain.
Visit us at www.clevelandclinicabudhabi.ae.
GE Healthcare is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience and leadership in the healthcare industry and more than 50,000 employees globally, GE Healthcare helps healthcare providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world. Follow us on Facebook, LinkedIn, Twitter and The Pulse for latest news, or visit our website www.gehealthcare.com for more information.
Known for clinical excellence we provide elite medial solutions to healthcare professionals around the world.
At Prometheus Medical we're passionate about improving patient safety, care and treatment through innovative products, world-class training and unique medical support.
Our focussed team of clinical experts has extensive experience in pre-hospital trauma care, major incident and disaster management, primary care and expedition medicine.
We deliver unrivalled emergency medical solutions to National Health Services, military and law enforcement, corporate and charitable organisations worldwide.
For more information visit: www.prometheusmed.com
The International Emergency Department Leadership Institute (IEDLI) is the world’s premier executive education program for emergency department leaders. For information on our courses and how you can become a Certified Emergency Department Executive (CEDE) visit IEDLI.org.
Quality, professionalism, and reliability are the benchmarks of PRO-MED Medical Co. We are serving the health care sector of UAE, and GCC for over 20 years.
Our major clients include UAE Army, Abu Dhabi & Dubai Police, Ministry of Health, SEHA, Red Crescent, National Ambulance, ADNOC, & many others.
Promed is dealing in Emergency & Life Support items, Tactical Rescue Survival & first Aid, Hospital Supplies, PPE & safety products, anti-microbial medical uniforms. All these items are manufactured by well-known partners from all around the world.
As an experienced industry leader in the field of medical devices, we’re used to working with all types of customers - local or global, large or small. Exceptional quality is the foundation of our company, and is the driving force behind all decisions; whether it’s which equipment to provide or the best way to serve our customers.
Our high-quality solutions are suitable for all areas of the market, ranging from hospitals and ambulances, to the military and air rescue operations. Whether its ventilation, resuscitation, anesthesia, patient handling or even infusion therapy, MEAD Medical will provide you with the solution that best fits your needs.
Stryker’s Medical division develops innovative medical equipment focused on improving outcomes for patients and caregivers. We offer a broad portfolio of products across the continuum of patient care; from the workplace to the ambulance, into the emergency department and through patient discharge. Our product portfolio includes, but is not limited to: powered EMS equipment, resuscitation devices, connected hospital beds, electric stretchers, temperature management systems and preventative skin injury and infection solutions. We are focused on safety, prevention, and ease of use – bringing caregivers confidence and delivering proven outcomes.
The Menarini Group is present in 136 countries worldwide, a guarantee of internationally recognised quality. The achieved results are proof of an efficient strategy based on Research, Innovation and Internationalisation, along with the ability to recognize and meet the needs of physicians and patients alike.
One of the Menarini Group's strong points is its collaboration with international partners: the goal is to create synergies that give rise to cutting-edge solutions, pharmaceutical products, and services in the health sector.
At Menarini, quality is the basis of a shared Group strategy. All company structures are involved at different levels in the drug manufacturing process: an efficient system that has created a unique work standard for ensuring quality in every phase, from research to production, from distribution to providing scientific information. All for achieving a common goal: excellence.
“Health without borders”, with this vision Menarini makes the difference.
GulfDrug has been on the forefront of providing the most innovative medical technologies to customers in the UAE since 1980. It is one of the most trusted names in the industry for quality and service of medical equipment.
Aerogen is the world’s leading medical device company specialising in the design, manufacture & commercialisation of aerosol drug delivery systems. Aerogen’s patented vibrating mesh technology turns liquid medication into a fine particle mist, gently & effectively delivering drugs to the lungs of critically ill patients. Their innovative products significantly improve aerosol drug delivery resulting in better patient outcomes throughout the hospital.
The company, synonymous with scientific excellence, and with a wealth of international awards, has a strong international presence with offices in Ireland, UK, Germany, United States, Middle East, Asia and India. Employing over 200 people worldwide and partnering their technology with the leading mechanical ventilation companies, Aerogen’s products have benefitted over 8 million respiratory patients worldwide.